A Randomized Double-blind Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures

Brief description of study

see synopsis

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    epilepsy,seizure
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 29 May 2023. Study ID: 832213

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center